[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Dr. Scott  Koenig M.D., Ph.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1090301, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Karrels", "age": 57, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen L. Eck M.D., Ph.D.", "age": 69, "title": "Senior VP of Clinical Development & Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 735308, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 57, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 70, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 53, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "age": 56, "title": "VP, Controller & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.49, "open": 1.5, "dayLow": 1.425, "dayHigh": 1.555, "regularMarketPreviousClose": 1.49, "regularMarketOpen": 1.5, "regularMarketDayLow": 1.425, "regularMarketDayHigh": 1.55, "payoutRatio": 0.0, "beta": 2.193, "forwardPE": -0.6431535, "volume": 172487, "regularMarketVolume": 172487, "averageVolume": 747786, "averageVolume10days": 572180, "averageDailyVolume10Day": 572180, "bid": 1.11, "ask": 1.85, "bidSize": 2, "askSize": 2, "marketCap": 97789960, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 14.91, "priceToSalesTrailing12Months": 0.65209824, "fiftyDayAverage": 1.7385, "twoHundredDayAverage": 3.04565, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -70201416, "profitMargins": -0.44654998, "floatShares": 51744790, "sharesOutstanding": 63090300, "sharesShort": 5338147, "sharesShortPriorMonth": 4972906, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0846, "heldPercentInsiders": 0.02922, "heldPercentInstitutions": 0.90984, "shortRatio": 5.39, "shortPercentOfFloat": 0.1041, "impliedSharesOutstanding": 63090300, "bookValue": 1.847, "priceToBook": 0.83919865, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -66966000, "trailingEps": -1.07, "forwardEps": -2.41, "enterpriseToRevenue": -0.468, "enterpriseToEbitda": 0.681, "52WeekChange": -0.8984322, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.55, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 6.0, "targetMedianPrice": 7.0, "recommendationMean": 2.375, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 201667008, "totalCashPerShare": 3.196, "ebitda": -103038000, "totalDebt": 37461000, "quickRatio": 3.709, "currentRatio": 3.917, "totalRevenue": 149962000, "debtToEquity": 32.278, "revenuePerShare": 2.395, "returnOnAssets": -0.24679, "returnOnEquity": -0.4985, "grossProfits": -39531000, "freeCashflow": -32491124, "operatingCashflow": -68373000, "revenueGrowth": 0.805, "grossMargins": -0.26361, "ebitdaMargins": -0.68709, "operatingMargins": -2.73017, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "marketState": "REGULAR", "regularMarketTime": 1746724155, "earningsTimestamp": 1747166400, "earningsTimestampStart": 1747166400, "earningsTimestampEnd": 1747166400, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.07, "epsForward": -2.41, "epsCurrentYear": -2.89, "priceEpsCurrentYear": -0.53633213, "fiftyDayAverageChange": -0.18850005, "fiftyDayAverageChangePercent": -0.10842683, "twoHundredDayAverageChange": -1.49565, "twoHundredDayAverageChangePercent": -0.49107745, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "regularMarketChange": 0.059999943, "regularMarketDayRange": "1.425 - 1.55", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 747786, "fiftyTwoWeekLowChange": 0.55999994, "fiftyTwoWeekLowChangePercent": 0.5656565, "fiftyTwoWeekRange": "0.99 - 14.91", "fiftyTwoWeekHighChange": -13.36, "fiftyTwoWeekHighChangePercent": -0.8960429, "fiftyTwoWeekChangePercent": -89.843216, "regularMarketChangePercent": 4.0268416, "regularMarketPrice": 1.55, "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]